Principal Investigator
Dr Amar Mohammed Ali is an experienced clinician and Principal Investigator with a broad background in acute, community, and research-based medicine. Throughout his clinical career, he has worked across a range of healthcare settings, developing expertise in patient assessment, diagnosis, management, and multidisciplinary care. His clinical experience has provided a strong foundation for his research leadership, enabling him to bridge the gap between frontline patient care and the generation of high-quality clinical evidence.
As a Principal Investigator, Dr Ali has extensive experience leading late phase clinical trials across dermatology, respiratory medicine, infectious diseases, and vaccines. He has served as Principal Investigator on numerous international multicentre studies involving conditions such as plaque psoriasis, chronic spontaneous urticaria, asthma, COPD, and vaccine-preventable diseases. He has also held the role of National Chief Investigator for a UK multicentre COPD study, providing scientific and operational leadership across participating research sites.
In addition to his clinical and research responsibilities, Dr Ali has significant experience in protocol implementation, patient recruitment, informed consent, safety oversight, regulatory compliance, staff training, and quality management. He regularly collaborates with sponsors, CROs, investigators, and healthcare professionals to ensure the successful delivery of complex clinical studies while maintaining the highest standards of patient safety and scientific integrity.
Dr Ali is passionate about advancing medical knowledge through clinical research and is particularly interested in the development of innovative therapies and vaccines that improve patient outcomes and address unmet healthcare needs.